Efficacy of secukinumab and adalimumab in psoriatic arthritis patients with moderate-to-severe plaque psoriasis: Results from the EXCEED study

被引：0
|
作者：
Gottlieb, Alice B. [1 ]
Merola, Joseph F. [2 ]
Reich, Kristian [3 ]
Behrens, Frank [4 ,5 ]
Nash, Peter [6 ]
Bao, Weibin [7 ]
Pellet, Pascale [8 ]
Pricop, Luminita [7 ]
McInnes, Iain B. [9 ]
机构：
[1] Icahn Sch Med, New York, NY USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Inst Hlth Serv Res Dermatol, Translat Res Inflammatory Skin Dis, Hamburg, Germany
[4] Univ Hosp, Rheumatol, Frankfurt, Germany
[5] Goethe Univ, Frankfurt, Germany
[6] Griffith Univ, Brisbane, Qld, Australia
[7] Novartis Pharmaceut, E Hanover, NJ USA
[8] Novartis Pharma AG, Basel, Switzerland
[9] Univ Glasgow, Glasgow, Lanark, Scotland
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
26248
引用
收藏
页码：AB92 / AB92
页数：1
相关论文
共 50 条
  • [1] Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate-to-severe plaque psoriasis: results from EXCEED, a randomized, double-blind head-to-head monotherapy study
    Gottlieb, A. B.
    Merola, J. F.
    Reich, K.
    Behrens, F.
    Nash, P.
    Griffiths, C. E. M.
    Bao, W.
    Pellet, P.
    Pricop, L.
    McInnes, I. B.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (06) : 1124 - 1134
  • [2] Secukinumab efficacy in subjects with moderate-to-severe plaque psoriasis and concomitant psoriatic arthritis: A subanalysis of the ERASURE study
    Blauvelt, Andrew
    Gottlieb, Alice
    Sigurgeirsson, Bardur
    Papavassilis, Charis
    Martin, Ruvie
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB2 - AB2
  • [3] Comparative efficacy of secukinumab against adalimumab and infliximab in patients with moderate-to-severe plaque psoriasis
    Pan Ran
    Wang Xiaolun
    Shu Min
    Das Jaydeep
    Kalra Manik
    Wang Zhidong
    [J]. 中华医学杂志(英文版), 2022, 135 (01) : 11 - 19
  • [4] Comparative efficacy of secukinumab against adalimumab and infliximab in patients with moderate-to-severe plaque psoriasis
    Pan, Ran
    Wang, Xiaolun
    Shu, Min
    Das, Jaydeep
    Kalra, Manik
    Wang, Zhidong
    [J]. CHINESE MEDICAL JOURNAL, 2022, 135 (01) : 11 - 19
  • [5] Adalimumab efficacy and safety results in patients with moderate to severe chronic plaque psoriasis with and without psoriatic arthritis
    Menter, MA
    Gordon, K
    Leonardi, C
    Chen, D
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P174 - P174
  • [6] Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study
    Blauvelt, Andrew
    Armstrong, April W.
    Langley, Richard G.
    Gebauer, Kurt
    Thaci, Diamant
    Bagel, Jerry
    Guenther, Lyn C.
    Paul, Carle
    Randazzo, Bruce
    Flavin, Susan
    Hsu, Ming-Chun
    You, Yin
    Reich, Kristian
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) : 2317 - 2324
  • [7] Sustained Efficacy of Ixekizumab in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Psoriatic Arthritis
    Papp, Kim
    Gottlieb, Alice B.
    Shuler, Catherine L.
    Burge, Russel T.
    Cameron, Gregory
    Kerr, Lisa
    Mease, Philip J.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [8] Secukinumab in subjects with moderate-to-severe plaque psoriasis: Results from the Efficacy of Response and Safety of 2 fixed secUkinumab REgimens in psoriasis (ERASURE)
    Elewski, B.
    Lebwohl, M.
    Papp, K.
    Nakagawa, H.
    Sigurgeirsson, B.
    Tsai, T. -F.
    Tyring, S.
    Hampele, I.
    Karpov, A.
    Helou, S.
    Papavassilis, C.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2014, 55 : 43 - 43
  • [9] Secukinumab in subjects with moderate-to-severe plaque psoriasis: Results from the Efficacy of Response And Safety of 2 fixed secUkinumab REgimens in psoriasis (ERASURE)
    Elewski, B.
    Lebwohl, M.
    Papp, K.
    Nakagawa, H.
    Sigurgeirsson, B.
    Tsai, T.
    Tyring, S.
    Hampele, I.
    Karpov, A.
    Helou, S.
    Papavassilis, C.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 15 - 15
  • [10] Maintenance regimen of secukinumab in subjects with moderate-to-severe plaque psoriasis: Results from the OPTIMISE study
    Reich, Kristian
    Puig, Lluis
    Szepietowski, Jacek C.
    Paul, Carle
    Lacour, Jean Philippe
    Tsianakas, Athanasios
    Sieder, Christian
    Rissler, Michael
    Jagiello, Piotr
    Orsenigo, Roberto
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB90 - AB90
12345